SC 13G/A | 2024-01-11 | FR Capital Holdings, L.P. | Notable Labs, Ltd. | 271,933 | 3.0% | EDGAR |
SC 13G | 2023-10-26 | B Capital Fund II, L.P. | Notable Labs, Ltd. | 1,002,254 | 11.2% | EDGAR |
SC 13G | 2023-10-26 | FR Capital Holdings, L.P. | Notable Labs, Ltd. | 1,037,345 | 11.6% | EDGAR |
SC 13D | 2023-10-19 | Builders VC Fund I (Canada), L.P. | Notable Labs, Ltd. | 305,306 | - | EDGAR |
SC 13G | 2022-02-01 | Slager David Mark | Vascular Biogenics Ltd. | 1,812,913 | 2.6% | EDGAR |
SC 13G/A | 2022-01-31 | Aurum Ventures M.K.I. Ltd. | Vascular Biogenics Ltd. | 6,839,059 | 9.9% | EDGAR |
SC 13D/A | 2021-11-15 | Thai Lee Family Trust | Vascular Biogenics Ltd. | 10,869,308 | 14.7% | EDGAR |
SC 13G/A | 2020-08-03 | Aurum Ventures M.K.I. Ltd. | Vascular Biogenics Ltd. | 6,839,059 | 13.9% | EDGAR |
SC 13D/A | 2020-05-26 | Thai Lee Family Trust | Vascular Biogenics Ltd. | 6,001,531 | 12.1% | EDGAR |
SC 13G | 2020-05-18 | ARMISTICE CAPITAL, LLC | Vascular Biogenics Ltd. | 2,198,560 | 5.0% | EDGAR |
SC 13G/A | 2020-02-13 | Aurum Ventures M.K.I. Ltd. | Vascular Biogenics Ltd. | 4,299,377 | 12.0% | EDGAR |
SC 13G/A | 2020-01-21 | SABBY MANAGEMENT, LLC | Vascular Biogenics Ltd. | 1,789,188 | 5.0% | EDGAR |
SC 13G/A | 2019-08-01 | Pitango Venture Capital Fund IV, L.P. | Vascular Biogenics Ltd. | 1,623,570 | 4.5% | EDGAR |
SC 13G/A | 2019-02-14 | CVI Investments, Inc. | Vascular Biogenics Ltd. | 1,810,883 | 4.9% | EDGAR |
SC 13G/A | 2019-01-17 | Empery Asset Management, LP | Vascular Biogenics Ltd. | 627,202 | 5.0% | EDGAR |
SC 13G/A | 2019-01-07 | SABBY MANAGEMENT, LLC | Vascular Biogenics Ltd. | 2,373,203 | 6.6% | EDGAR |
SC 13G | 2018-07-03 | CVI Investments, Inc. | Vascular Biogenics Ltd. | 1,904,762 | 5.3% | EDGAR |
SC 13G | 2018-06-28 | Empery Asset Management, LP | Vascular Biogenics Ltd. | 1,904,762 | 5.3% | EDGAR |
SC 13G | 2018-06-26 | SABBY MANAGEMENT, LLC | Vascular Biogenics Ltd. | 1,904,762 | 5.3% | EDGAR |
SC 13D/A | 2018-02-21 | Thai Lee Family Trust | Vascular Biogenics Ltd. | 2,192,007 | 8.1% | EDGAR |